Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer Female
Interventions: DRUG: Palbociclib|DRUG: Letrozole
Sponsor: Pfizer